Status:
COMPLETED
Virtual Reality Distraction for Reduction
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Using a randomized controlled design, the investigators goal is to estimate the effect of VR on postoperative analgesia and opioid consumption.
Detailed Description
Specifically, the investigators propose to test the primary hypothesis that the use of AppliedVR software in Pico G2 4K headsets decreases acute postoperative pain scores (with a 1 point difference co...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- American Society of Anesthesiology Physical Status 1-3;
- Scheduled for elective, primary total hip arthroplasty;
- Anticipated hospitalization of at least 1 night;
- Expected to require parenteral opioids for postoperative pain;
- Able to use IV PCA systems.
- Exclusion criteria:
- History of chronic pain or care by a pain management specialist;
- Use of more than 30 mg/day of oral oxycodone (or equivalent);
- Greater than 12 weeks of current and continued opioid use;
- History of seizures, epilepsy, motion sickness, stroke, dementia;
- Non-English speaking;
- Women who are pregnant or breastfeeding;
- History of substance use disorder.
Exclusion
Key Trial Info
Start Date :
August 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 3 2022
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT04416555
Start Date
August 3 2020
End Date
May 3 2022
Last Update
November 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Fairview Hospital
Cleveland, Ohio, United States, 44111